BTC $78,218.02 -0.96%
ETH $2,451.06 -0.58%
BNB $697.46 -0.16%
XRP $1.38 -5.96%
SOL $96.33 -1.38%
TRX $0.3342 -2.02%
DOGE $0.0844 -4.57%
ADA $0.2051 -4.33%
BCH $259.70 -2.54%
LINK $11.24 -2.12%
HYPE $80.15 -1.56%
AAVE $123.08 -3.26%
SUI $0.7385 -5.34%
XLM $0.1790 -5.81%
ZEC $771.43 -3.91%
BTC $78,218.02 -0.96%
ETH $2,451.06 -0.58%
BNB $697.46 -0.16%
XRP $1.38 -5.96%
SOL $96.33 -1.38%
TRX $0.3342 -2.02%
DOGE $0.0844 -4.57%
ADA $0.2051 -4.33%
BCH $259.70 -2.54%
LINK $11.24 -2.12%
HYPE $80.15 -1.56%
AAVE $123.08 -3.26%
SUI $0.7385 -5.34%
XLM $0.1790 -5.81%
ZEC $771.43 -3.91%

生物科技公司 BioNexus Gene Lab 董事会批准将部分资金配置于以太坊生态系统

2025-03-06 10:21:06

ChainCatcher 消息,据 Globe Newswire 报道,生物科技公司 BioNexus Gene Lab Corp 董事会已批准以太坊财库战略并发布相关战略白皮书,将部分资金配置于以太坊生态系统。

该公司表示,这一战略旨在优化公司财务管理,同时探索区块链技术在生物科技领域的应用潜力。战略白皮书详细阐述了公司如何利用以太坊网络的智能合约功能和去中心化特性,为其业务发展创造新机遇。

app_icon
ChainCatcher Building the Web3 world with innovations.